0
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.80.226.90. Please contact the publisher to request reinstatement.
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Image of JAMA Network Reader promo

Image of JAMA forum logo

Become a subscriber
Topic Image
JAMA offers groundbreaking research and insightful commentary from leaders across the broad spectrum of health care. Subscribe/Learn More >

Latest Content

Twitter Facebook

Follow Us

JAMA

JAMA Cardiology

JAMA Dermatology

JAMA Facial Plastic Surgery

JAMA Internal Medicine

JAMA Neurology

JAMA Oncology

JAMA Ophthalmology

JAMA Otolaryngology–Head & Neck Surgery

JAMA Pediatrics

JAMA Psychiatry

JAMA Surgery

Journal of the American Medical Association
Current Issue >
Please Wait... Processing your request... Please Wait.

Current Highlights

Multimedia from The JAMA Network

JAMA Multimedia > Author Interview >

Author Interview Thumbnail

Richard N. Rosenthal, MD discusses a randomized clinical trial demonstrating the efficacy of an implantable buprenorphine-releasing device for treating opioid use disorder.

 

audio player

RELATED ARTICLE:

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine A Randomized Clinical Trial
JAMA. 2016;316(3):282-290
Richard N. Rosenthal, MD; Michelle R. Lofwall, MD; Sonnie Kim, PharmD; Michael Chen, PhD; Katherine L. Beebe, PhD; Frank J. Vocci, PhD; for the PRO-814 Study Group

All Author Interviews >

Physician Jobs